55
Views
25
CrossRef citations to date
0
Altmetric
Original Article

A Study of the Sero-immunity That Has Protected the Swedish Population against Poliomyelitis for 25 Years

Pages 595-601 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

KarenM. Farizo, StephenL. Cochi & PeterA. Patriarca. (1990) Poliomyelitis in the United States: A Historical Perspective and Current Vaccination Policy. Journal of American College Health 39:3, pages 137-143.
Read now

Articles from other publishers (24)

Arun K Sharma, Harish Verma, Concepcion F Estivariz, Luna Bajracharaya, Ganesh Rai, Ganesh Shah, Jeevan Sherchand, Kathryn A V Jones, Bernardo A Mainou, Smita Chavan, Vishali Jeyaseelan, Roland W Sutter & Laxman P Shrestha. (2023) Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trial. The Lancet Microbe 4:11, pages e923-e930.
Crossref
Paul E.M. Fine, Kim Mulholland, J. Anthony Scott & W. John Edmunds. 2023. Plotkin's Vaccines. Plotkin's Vaccines 1603 1624.e8 .
Stephanie B. Troy & Yvonne A. Maldonado. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases 1225 1228.e1 .
Stephanie B. Troy & Yvonne A. Maldonado. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases 1201 1205.e1 .
Paul E.M. Fine, Kim Mulholland, J. Anthony Scott & W. John Edmunds. 2018. Plotkin's Vaccines. Plotkin's Vaccines 1512 1531.e5 .
Sonia Resik, Alina Tejeda, Roland W. Sutter, Manuel Diaz, Luis Sarmiento, Nilda Alemañi, Gloria Garcia, Magilé Fonseca, Lai Heng Hung, Anna-Lea Kahn, Anthony Burton, J. Mauricio Landaverde & R. Bruce Aylward. (2013) Priming after a Fractional Dose of Inactivated Poliovirus Vaccine. New England Journal of Medicine 368:5, pages 416-424.
Crossref
Paul E.M. Fine & Kim Mulholland. 2013. Vaccines. Vaccines 1395 1412 .
Stephanie B. Troy & Yvonne A. Maldonado. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases 1168 1172.e1 .
John Clemens, Sunheang Shin & Mohammad Ali. (2011) New approaches to the assessment of vaccine herd protection in clinical trials. The Lancet Infectious Diseases 11:6, pages 482-487.
Crossref
P. Fine, K. Eames & D. L. Heymann. (2011) "Herd Immunity": A Rough Guide. Clinical Infectious Diseases 52:7, pages 911-916.
Crossref
Ali Jafer Mohammed, Salah AlAwaidy, Shyam Bawikar, Padmamohan J. Kurup, Emadaldin Elamir, Mahmoud M.A. Shaban, Sharif M. Sharif, Harrie G.A.M. van der Avoort, Mark A. Pallansch, Pradeep Malankar, Anthony Burton, Meghana Sreevatsava & Roland W. Sutter. (2010) Fractional Doses of Inactivated Poliovirus Vaccine in Oman. New England Journal of Medicine 362:25, pages 2351-2359.
Crossref
Ian J. Amanna & Mark K. Slifka. (2009) Wanted, dead or alive: New viral vaccines. Antiviral Research 84:2, pages 119-130.
Crossref
Paul E.M. Fine & Kim Mulholland. 2008. Vaccines. Vaccines 1573 1592 .
Yvonne A. Maldonado. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease 1146 1149 .
David B. Huang, Jashin J. Wu & Stephen K. Tyring. (2004) A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines. Journal of Infection 49:3, pages 179-209.
Crossref
I. Pachón del Amo. (2004) La vacuna inactivada de la polio. Atención Primaria 34:8, pages 392-394.
Crossref
ROSE-MARIE CARLSSON, BO A. CLAESSON, EVA FAGERLUND, NINA KNUTSSON & CLAUS LUNDIN. (2002) Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy. The Pediatric Infectious Disease Journal 21:6, pages 535-541.
Crossref
ROSE-MARIE CARLSSON, BO A. CLAESSON, URBAN SELSTAM, EVA FAGERLUND, MARTA GRANSTRÖM, CHRISTINE BLONDEAU & AGNÈS HOFFENBACH. (1998) Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age. The Pediatric Infectious Disease Journal 17:11, pages 1026-1033.
Crossref
I. Mastroeni, A.M. Patti, A. Fabrizi, A.L. Santi, A. Marinaro Manduca, N. Vescia, S. Squarcione & G.M. Fara. (1997) Immunity status against poliomyelitis in persons 13–14 years old living in Rome. Vaccine 15:6-7, pages 747-750.
Crossref
. (1997) Poliomyelitis Prevention: Recommendations for Use of Inactivated Poliovirus Vaccine and Live Oral Poliovirus Vaccine. Pediatrics 99:2, pages 300-305.
Crossref
H. Faden. 1993. Measles and Poliomyelitis. Measles and Poliomyelitis 315 332 .
Roland W Sutter, Ida M Onorato & Peter A Patriarca. (1990) Current Poliomyelitis Immunization Policy in the United States. Pediatric Annals 19:12, pages 702-706.
Crossref
Margareta Böttiger. (1990) Polio immunity to killed vaccine: an 18-year follow-up. Vaccine 8:5, pages 443-445.
Crossref
Tapani Hovi. 1989. Advances in Virus Research Volume 37. Advances in Virus Research Volume 37 243 275 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.